Этические аспекты применения полногеномного неинвазивного пренатального тестирования

Неинвазивный пренатальный тест (НИПТ) – современный молекулярно-генетический метод, применяемый для скрининга хромосомной патологии у плода путем выделения и секвенирования свободно циркулирующих фрагментов ДНК плода и плаценты в крови матери (внеклеточная фетоплацентарная ДНК). НИПТ стал активно применяться в клинической практике сравнительно недавно – с начала прошлого десятилетия, в связи с чем нет единого мнения и решений этических вопросов, связанных с тестированием. Селекция пола, формирование спектра выявляемых рисков, медико-генетическое консультирование, дискриминация детей с хромосомными аномалиями и их родителей, «рутинизация» метода – основные этические проблемы, с которыми сталкиваются врачи различных специальностей и пациенты. Влияние результата НИПТ на репродуктивный выбор семейных пар сложно недооценить, поэтому применение теста в системе пренатального скрининга требует особого внимания, консультирования и участия специалистов разных областей медицины и не только.

1. Liao C., Yin A.H., Peng C.F., et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci U S A. 2014;111(20):7415-7420.

2. Lo Y.M., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485-487.

3. CNN. A blood test before birth could predict your medical destiny – URL: https://us.cnn.com/2016/03/24/health/dennis-lo-dna-discovery/index.html.

4. Horn R. NIPT and the concerns regarding ‘routinisation’. Eur J Hum Genet. 2022;30(6):637-638.

5. Akolekar R., Beta J., Picciarelli G., et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(1):16-26.

6. van Schendel R.V., Kleinveld J.H., Dondorp W.J., et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet. 2014;22(12):1345–50.

7. Hill M., Johnson J.-A., Langlois S., et al. Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals. Eur J Hum Genet. 2015;24(7):968–975.

8. Benachi A., Caffrey J., Calda P., et al. Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): a survey of European health-care providers. Eur J Med Genet. 2020;63(1):103616.

9. Yu D., Zhang K., Han M., et al. Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing. Mol Genet Genomic Med. 2019;7(6):674.

10. Баранова Е.Е., Беленикин М.С., Жученко Л.А., Ижевская В.Л. Неинвазивные пренатальные тесты: европейские и американские рекомендации по применению в клинической практике. Медицинская генетика. 2017;16(8):3-10

11. Papageorgiou E.A., Patsalis P.C. Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications. Genome Med. 2012;4(5):46.

12. Suciu I.D., Toader O.D., Galeva S., Pop L. Non-Invasive Prenatal Testing beyond Trisomies. J Med Life. 2019;12(3):221-224.

13. Lefkowitz R.B., Tynan J.A., Liu T., et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol. 2016;215(2):227.

14. Chen Y., Yang F., Shang X., et al. A study on non-invasive prenatal screening for the detection of aneuploidy. Ginekol Pol. 2022;93(9):716720.

15. Soukkhaphone B., Lindsay C., Langlois S., et al. Non-invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: A systematic review and meta-analysis of diagnostic test accuracy studies. Mol Genet Genomic Med. 2021;9(5):1654.

16. Оленев А.С., Баранова Е.Е., Сагайдак О.В. и др. Случайные находки при использовании полногеномного неинвазивного пренатального теста: клинические и этические аспекты. Проблемы репродукции. 2021;27(1):78-87.

17. Benn P. Trisomy 16 and trisomy 16 Mosaicism: a review. Am J Med Genet. 1998;79(2):121-33.

18. Badeau M., Lindsay C., Blais J., et al. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. Cochrane Database Syst Rev. 2017;11(11):CD011767.

19. Clarke A. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). J Med Genet. 1994;31(10):785-797.

20. Perrot A., Horn R. The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review. Eur J Hum Genet. 2022;30(6):676-681.

21. van der Meij K.R.M., Sistermans E.A., Macville M.V.E., et al. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. Am J Hum Genet. 2019;105(6):1091-1101.

22. Dondorp W., de Wert G., Bombard Y., et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23(11):1438-1450.

23. Rose N.C., Kaimal A.J., Dugoff L., et al. Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin, Number 226. Obstetrics & Gynecology. 2020; 136(4):e48-e69.

24. de Graaf G., Buckley F., Skotko B.G. Estimation of the number of people with Down syndrome in Europe. Eur J Hum Genet. 2021;29(3):402-410.

25. Cavaliere G. Looking into the shadow: the eugenics argument in debates on reproductive technologies and practices. Monash Bioeth Rev. 2018;36(1-4):1-22.

26. Savulescu J., Kahane G. The moral obligation to create children with the best chance of the best life. Bioethics. 2009;23(5):274-290.

27. Zaami S., Orrico A., Signore F., et al. Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices. Genes (Basel). 2021;12(2):204.

28. Приказ Минздрава России от 20.10.2020 №1130н «Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология». – URL: http://publication.pravo.gov.ru/Document/View/0001202011130037

29. Приказ Министерства здравоохранения и социального развития РФ от 3 декабря 2007 г. № 736 «Об утверждении перечня медицинских показаний для искусственного прерывания беременности». – URL: http://pravo.gov.ru/proxy/ips/?docbody=&link_id=15&nd=102120553

30. Zerres K., Rudnik-Schöneborn S., Holzgreve W. Do non-invasive prenatal tests promote discrimination against people with Down syndrome? What should be done? J Perinat Med. 2021;49(8):965-971.

31. Buechner B. German Ethics Council on genetic diagnostics: trend setting? Eur J Hum Genet. 2014;22(6):831-832.

32. Mackie F.L., Hemming K., Allen S., et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG. 2017;124(1):32-46.

33. Salomon L.J., Sotiriadis A., Wulff C.B., et al. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54(4):442-451.

34. Robitaille M.-C., Chatterjee I. Sex-selective abortions and infant mortality in India: The role of parents’ stated son preference. J Dev Stud. 2018;54(1):47-56.

35. Hesketh T., Lu L., Xing Z.W. The consequences of son preference and sex-selective abortion in China and other Asian countries. CMAJ Open. 2011;183(12):1374-1377.

36. Duthé G., Meslé F., Vallin J., et al. High sex ratios at birth in the Caucasus: modern technology to satisfy old desires. Popul Dev Rev. 2012;38(3):487-501

37. Hesketh T., Xing Z.W. Abnormal sex ratios in human populations: causes and consequences. Proc Natl Acad Sci U S A. 2006;103(36):13271-13275.

38. Salame A.A., Nassif J., Ghazeeri G.S., et al. The effect of religious background on the attitude towards sex selection. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100052.

39. Parliamentary Assembly of the Council of Europe. Committee on Equal Opportunities for Women and Men. Prenatal sex selection. URL: https://assembly.coe.int/nw/xml/XRef/Xref-XML2HTML-en.asp?fileid=13158=en.

40. Sebastian M., Khan M.E., Sebastian D. Unintended pregnancy and abortion in India: Country profile report. 2014.

41. National Commission for Protection of Child Rights. Pre-Conception & Pre-Natal Diagnostic Techniques Act, 1994. – URL: https://ruralindiaonline.org/or/library/resource/pre-conception-pre-natal-diagnostic-techniques-act-1994/

42. Malik Y. Beti Bachao Beti Padhao Scheme, Haryana: Improvement in sex ratio at birth and other achievements. Indian Journal of Community and Family Medicine. 2021;7(1):68.

43. United Nations. The 2022 Revision of World Population Prospects. – URL: https://population.un.org/wpp/.

44. Bowman-Smart H., Savulescu J., Gyngell C., Mand C., Delatycki M.B. Sex selection and non-invasive prenatal testing: A review of current practices, evidence, and ethical issues. Prenatal Diagnosis. 2020;40(4):398–407.

45. Lee J., Smith J.P. Fertility behaviors in South Korea and their association with ultrasound prenatal sex screening. SSM Popul Health. 2017;4:10-16.

46. Wilhelm M., Dahl E., Alexander H., Brähler E., Stöbel-Richter Y. Ethical attitudes of German specialists in reproductive medicine and legal regulation of preimplantation sex selection in Germany. PLoS One. 2013;8(2):e56390.

47. Федеральный закон от 21.11.2011 № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации». – URL: https://minzdrav.gov.ru/documents/7025

48. Benn P., Cuckle H., Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol. 2013;42(1):15-33.

49. McCabe L.L., McCabe E.R. Down syndrome: coercion and eugenics. Genet Med. 2011;13(8):708-710.

50. Skotko B., Canal Bedia R. Postnatal support for mothers of children with Down syndrome. Ment Retard Dev Disabil Res Rev. 2005;43(3):196–212.

51. Korenromp M.J., Page-Christiaens G.C.M.L., van den Bout J., et al. Maternal decision to terminate pregnancy after a diagnosis of Down syndrome. Am J Obstet Gynecol. 2007;196(2):149.e1-149.e11.

52. Gekas J., Langlois S., Ravitsky V., et al. Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues. Appl Clin Genet. 2016;(9):15-26.

53. Ижевская В.Л. Этические проблемы пренатальной диагностики. Журнал акушерства и женских болезней. 2011; 60(3):203-211.

54. Хусаинова Р.И., Ахтямова Е.В., Минниахметов И.Р., Алсынбаева Э.М. Правовые проблемы применения современных методов пренатальной генетической диагностики в России. Правовое государство: теория и практика. 2021; 2(64):52-64.

55. Carbone L., Cariati F., Sarno L., et al. Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges. Genes (Basel). 2020;12(1):15.

56. Samura O., Okamoto A. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review. Taiwan J Obstet Gynecol. 2020;59(1):16-20.

57. Harraway J. Non-invasive prenatal testing. Aust Fam Physician. 2017;46(10):735-739.

58. Schöne-Seifert B., Junker C. Making use of non-invasive prenatal testing (NIPT): rethinking issues of routinization and pressure. J Perinat Med. 2021;49(8):959-964.

59. van der Meij K.R.M., Njio A., Martin L. Routinization of prenatal screening with the non-invasive prenatal test: pregnant women’s perspectives. Eur J Hum Genet. 2022;30(6):661-668.

60. Lewis C., Hill M., Chitty L.S. Offering non-invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained? Prenat Diagn. 2017;37(11):1130-1137.